Literature DB >> 29080936

Detection of Candida species by nested PCR method in one-humped camels (Camelus dromedarius).

Ugur Parin1, Goksel Erbas2, Sukru Kirkan1, Serap Savasan1, H Tugba Yuksel1, Gamze Balat1.   

Abstract

Systemic fungal diseases are the infections caused by false treatment protocols and generally are not taken into consideration especially in the veterinary field. One-humped camels are found in the western side of the Aegean region of our country and bred for wrestling. The aim of this study is the application of diagnosing systemic fungi infection from camel blood samples by the PCR method. In this study, specific primers for DNA topoisomerase II gene sequences were used. As a result, a systemic fungal infection was detected by the nested PCR method from 10 (20%) out of 50 DNA samples taken from camels located on the western side of the Aegean region. In this study, 3 (30%) samples were identified as Candida albicans, 3 (30%) samples were identified as C. glabrata, and 4 (40%) samples were identified as C. parapsilosis. In conclusion, the 20% positive systemic fungal infection rate in one-humped camels observed in the present study showed that the systemic fungal infections are not taken into considerations in veterinary medicine. Further studies are suggested in order to obtain and to maintain extensive data for systemic fungal diseases in our country for one-humped camels.

Entities:  

Keywords:  Camelus dromedarius; Candida sp.; DNA topoisomerase II gene; Nested PCR

Mesh:

Substances:

Year:  2017        PMID: 29080936     DOI: 10.1007/s11250-017-1452-z

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  14 in total

1.  Phylogenetic relationship and mode of evolution of yeast DNA topoisomerase II gene in the pathogenic Candida species.

Authors:  M Kato; M Ozeki; A Kikuchi; T Kanbe
Journal:  Gene       Date:  2001-07-11       Impact factor: 3.688

2.  Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR.

Authors:  Anna Lau; Catriona Halliday; Sharon C-A Chen; E Geoffrey Playford; Keith Stanley; Tania C Sorrell
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

Review 3.  Invasive fungal infections: a review of epidemiology and management options.

Authors:  D A Enoch; H A Ludlam; N M Brown
Journal:  J Med Microbiol       Date:  2006-07       Impact factor: 2.472

4.  Assessment of the paradoxical effect of caspofungin in therapy of candidiasis.

Authors:  Karl V Clemons; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes.

Authors:  Toshio Kanbe; Toshinobu Horii; Takuo Arishima; Munetaka Ozeki; Akihiko Kikuchi
Journal:  Yeast       Date:  2002-08       Impact factor: 3.239

6.  New method for detection of Candida albicans in human blood by polymerase chain reaction.

Authors:  Y Miyakawa; T Mabuchi; Y Fukazawa
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

7.  Identification of Candida species isolated from bovine mastitic milk and their in vitro hemolytic activity in Western Turkey.

Authors:  Esra Seker
Journal:  Mycopathologia       Date:  2009-11-17       Impact factor: 2.574

8.  Improvements of PCR-based identification targeting the DNA topoisomerase II gene to determine major species of the opportunistic fungi Candida and Aspergillus fumigatus.

Authors:  Toshio Kanbe; Takuro Arishima; Toshinobu Horii; Akihiko Kikuchi
Journal:  Microbiol Immunol       Date:  2003       Impact factor: 1.955

Review 9.  Systemic Candida infections.

Authors:  L A Grohskopf; V T Andriole
Journal:  Yale J Biol Med       Date:  1996 Nov-Dec

10.  A multiplex nested PCR for the detection and identification of Candida species in blood samples of critically ill paediatric patients.

Authors:  Cleison Ledesma Taira; Thelma Suely Okay; Artur Figueiredo Delgado; Maria Esther Jurfest Rivero Ceccon; Margarete Teresa Gottardo de Almeida; Gilda Maria Barbaro Del Negro
Journal:  BMC Infect Dis       Date:  2014-07-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.